When did AGIOS PHARMACEUTICALS INC (AGIO) report earnings last quarter?
AGIOS PHARMACEUTICALS INC (AGIO) last reported earnings on 2/12/2026.
AGIOS PHARMACEUTICALS INC (AGIO) Earnings History & Surprises
NASDAQ:AGIO • US00847X1046
Current stock price
28.13 USD
-0.78 (-2.7%)
At close:
28.13 USD
0 (0%)
After Hours:
AGIO Earnings overview
Past quarterly earnings results for AGIOS PHARMACEUTICALS INC (AGIO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.85
- Revenue Estimate
- 13.901M
Last Reported
Most Recent- Release Date
- Feb 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$1.86
- EPS Surprise
- 6.31%
- Revenue Surprise
- 63.21%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.86 | -1.99 | 6.31% | -29.17% | 20M | 12.254M | 63.21% | 86.39% |
| Q3 2025 | -1.78 | -1.94 | 8.09% | 26.32% | 12.88M | 10.625M | 21.22% | 43.69% |
| Q2 2025 | -1.93 | -1.84 | -4.68% | -14.20% | 12.455M | 9.669M | 28.81% | 44.57% |
| Q1 2025 | -1.55 | -1.82 | 14.81% | -6.90% | 8.726M | 9.833M | -11.26% | 6.56% |
| Q4 2024 | -1.44 | -1.72 | 16.46% | 16.28% | 10.73M | 9.513M | 12.79% | 51.06% |
| Q3 2024 | -2.42 | 1.13 | -314.16% | -47.32% | 8.964M | 9.65M | -7.11% | 21.15% |
| Q2 2024 | -1.69 | -1.63 | -3.39% | -11.92% | 8.615M | 9.494M | -9.26% | 28.35% |
| Q1 2024 | -1.45 | -1.68 | 13.79% | 1.36% | 8.189M | 8.538M | -4.09% | 46.00% |
| Q4 2023 | -1.72 | -1.68 | -2.34% | -356.72% | 7.103M | 8.078M | -12.07% | 64.80% |
| Q3 2023 | -1.64 | -1.74 | 5.56% | -10.07% | 7.399M | 7.672M | -3.56% | 110.20% |
| Q2 2023 | -1.51 | -1.59 | 5.17% | 10.12% | 6.712M | 6.592M | 1.82% | 20.29% |
| Q1 2023 | -1.47 | -1.74 | 15.28% | 15.52% | 5.609M | 5.339M | 5.06% | 575.78% |
| Q4 2022 | 0.67 | -1.65 | 140.64% | 138.51% | 4.31M | 4.623M | -6.77% | - |
| Q3 2022 | -1.49 | -1.80 | 17.18% | 4.49% | 3.52M | 5.345M | -34.14% | - |
| Q2 2022 | -1.68 | -1.78 | 5.68% | -16.67% | 5.58M | 2.472M | 125.73% | - |
| Q1 2022 | -1.74 | -1.85 | 5.81% | -106.46% | 830K | 2.766M | -69.99% | - |
| Q4 2021 | -1.74 | -1.72 | -1.16% | -23.40% | 569.996K | -100.00% | - | |
| Q3 2021 | -1.56 | -1.62 | 3.75% | -9.09% | 2.648M | -100.00% | - | |
| Q2 2021 | -1.44 | -1.42 | -1.30% | -9.92% | 2.59M | -100.00% | - | |
| Q1 2021 | 26.95 | -1.34 | 2,104.00% | 4,667.80% | 45.492M | -100.00% | - | |
| Q4 2020 | -1.41 | -1.36 | -3.60% | - | 40.975M | -100.00% | - | |
| Q3 2020 | -1.43 | -1.41 | -1.71% | - | 38.783M | -100.00% | - | |
| Q2 2020 | -1.31 | -1.40 | 6.48% | - | 38.466M | -100.00% | - | |
| Q1 2020 | -0.59 | -1.70 | 65.27% | - | 31.446M | -100.00% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
6.13%
Max EPS beat (4)
14.81%
Min EPS beat (4)
-4.68%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
25.50%
Max Revenue beat (4)
63.21%
Min Revenue beat (4)
-11.26%
Analysis
In the last 4 quarters, AGIO has beaten EPS estimates in 3 out of 4 releases
AGIO has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, AGIO has beaten the EPS estimates by 6.1% on average.
In the last 4 quarters, AGIO has beaten the revenue estimates by 25.5% on average.
Related analysis
AGIOS PHARMACEUTICALS INC / AGIO Earnings FAQ
Did AGIOS PHARMACEUTICALS INC (AGIO) beat earnings estimates last quarter?
AGIOS PHARMACEUTICALS INC (AGIO) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often AGIOS PHARMACEUTICALS INC beats earnings estimates?
In the last 4 quarters, AGIOS PHARMACEUTICALS INC (AGIO) has beaten EPS estimates in 3 out of 4 releases.